Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Methotrexate

5

XV.f Path: Diffuse alveolar damage (DAD-pattern) (see also IL)

1
Last update : 18/10/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
DMARDs (disease-modifying antirheumatic drugs)
5
Pemetrexed
3

Publications

[Fatal pneumonitis during low-dose methotrexate treatment].
Zeitschrift fur Rheumatologie 2012 Jan;71;75-7 2012 Jan
Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients.
The European respiratory journal 2000 Feb;15;373-81 2000 Feb
Acute respiratory distress syndrome following intrathecal methotrexate administration: a case report and review of literature.
Annals of hematology 2000 Dec;79;696-9 2000 Dec
Lung disease associated with methotrexate therapy.
Australian and New Zealand journal of medicine 1974 Jun;4;277-80 1974 Jun
Methotrexate-induced pulmonary disease.
Journal of the Canadian Association of Radiologists 1973 Sep;24;215-20 1973 Sep

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies